rap chart, page-4036

What are you talking about??? I told you already I believe in these revolutionary technologies with massive revenue potential for acute respiratory disease, chronic respiratory management and OSA and now the clinically proven algorithm is gaining traction from big pharmaceutical....only a matter of when and not if.

"To have our technology licensed by a company of AstraZeneca’s reputation is a major achievement and provides significant validation of ResApp’s products and capability. They have some of the world’s leading scientists and researchers running clinical trials and treatment programs and we are confident that their input will enhance our technology for future commercial applications and deployments."